Predict your next investment

Mutual Fund
mutualfund.brilasunlife.com

See what CB Insights has to offer

Investments

4

Portfolio Exits

1

About Aditya Birla Sun Life Mutual Fund

Aditya Birla Sun Life Mutual Fund is a joint venture between the Aditya Birla Group and the Sun Life Financial Inc. of Canada. The joint venture brings together the Aditya Birla Group's experience in the Indian market and Sun Life's global experience. Its solutions offer a range of investment options, including diversified and sector specific equity schemes, fund of fund schemes, hybrid and monthly income funds, a wide range of debt and treasury products, and offshore funds.

Aditya Birla Sun Life Mutual Fund Headquarter Location

One India Bulls Centre Tower 1,17th Floor, Senapatl Bapat Marg, Elphinstone Rd

Mumbai, 400013,

India

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Aditya Birla Sun Life Mutual Fund News

Bulk Deals | Promoter offloads 1.26% stake in Lemon Tree, Fidelity picks 1.8% shares in Vijaya Diagnostic

Mar 26, 2022

Aditya Birla Sun Life Mutual Fund, UTI Mutual Fund, Abu Dhabi Investment Authority, and Segantii India Mauritius acquired 7.63 lakh equity shares in defence company MTAR Technologies via open market transactions at an average price of Rs 1,795 per share. Trade × JPMorgan Indian Investment Trust Plc acquired half a percent stake in Lemon Tree Hotels via open market transactions, while Fidelity has picked 1.8 percent shareholding in Vijaya Diagnostic Centre on March 25. The investment trust bought 42,71,589 equity shares in Lemon Tree at an average price of Rs 60 per share, while, promoter Spank Management Service sold 1 crore equity shares at same price. Lemon Tree Hotels stock closed at Rs 60.05 apiece on the BSE, up 7.81 percent from its previous close amid high volumes. Among other deals, Aditya Birla Sun Life Mutual Fund, UTI Mutual Fund, Abu Dhabi Investment Authority, and Segantii India Mauritius acquired 7.63 lakh equity shares in defence company MTAR Technologies via open market transactions at an average price of Rs 1,795 per share. BNP Paribas Arbitrage also bought 2.77 lakh shares at an average price of Rs 1,797.13 per share. However, Solidus Advisors LLP sold 4,89,530 equity shares in MTAR at an average price of Rs 1,796.41 per share, and Fabmohur Advisors LLP offloaded 19,42,382 shares at Rs 1,793.44 per share. MTAR shares settled at Rs 1,715.45 on the BSE, down 10.13 percent. Fidelity Investment Trust Fidelity Series Emerging Markets Fund bought 18,50,800 equity shares or 1.8 percent of total paid up equity in Vijaya Diagnostic Centre at an average price of Rs 445 per share. However, India-focussed private equity firm Kedaara-owned Karakoram offloaded 25,32,270 equity shares (2.48 percent stake) at same price. The stock gained 1.23 percent at Rs 436.95. Fidelity already held 5.54 percent stake in the company, and Karakoram's shareholding was 9.64 percent in Vijaya Diagnostic Centre as of December 2021. Poonawalla Constructions LLP sold 2,30,820 equity shares in BSE Limited via open market transactions. These shares were sold at an average price of Rs 891.88 per equity share. Crompton Greaves Consumer Electricals acquired 98,33,754 equity shares in Butterfly Gandhimathi Appliances via open market transactions at an average price of Rs 1,403 per share. With this, Crompton's shareholding stands at 55 percent in Butterfly Gandhimathi now. However, Butterfly Gandhimathi's promoters LLM Appliances, Seshadri V M, Viswanatha Murugesa Balasubramaniam, Viswanatha Murugesan Gangadharam, V M Chettiar & Sons India LLP, Viswanathan Murugesa Kumaresan, and Viwanathan Murugesachettiar Lakshminarayanan were the sellers in this block deals. The above transaction was in line with the share purchase agreement, dated February 22 this year, between Crompton Greaves Consumer Electricals, and promoters. Moneycontrol News

Aditya Birla Sun Life Mutual Fund Investments

4 Investments

Aditya Birla Sun Life Mutual Fund has made 4 investments. Their latest investment was in Alkem Laboratories as part of their PIPE on August 8, 2019.

CBI Logo

Aditya Birla Sun Life Mutual Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/22/2019

PIPE

Alkem Laboratories

$74.9M

Yes

1

8/1/2018

Debt - VI

Subscribe to see more

$99M

Subscribe to see more

10

7/31/2018

Debt - III

Subscribe to see more

$99M

Subscribe to see more

10

11/7/2017

Debt - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/22/2019

8/1/2018

7/31/2018

11/7/2017

Round

PIPE

Debt - VI

Debt - III

Debt - II

Company

Alkem Laboratories

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$74.9M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

Aditya Birla Sun Life Mutual Fund Portfolio Exits

1 Portfolio Exit

Aditya Birla Sun Life Mutual Fund has 1 portfolio exit. Their latest portfolio exit was Spandana Sphoorty Financial on August 07, 2019.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/7/2019

IPO

$99M

Public

1

Date

8/7/2019

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.